Back to search
Rare Bone Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rare Bone Disorders trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rare Bone Disorders trials you may qualify forOsteoporosis is a multifactorial disease in which genetic predispositions play a key role in its development. A better understanding of family history and clini…
Background: \- The rare disease melorheostosis causes bones to thicken. This may lead to pain, and can affect bones, joints, and muscles. Researchers want to l…
This is a study to assess the ability of Indocyanine Green (ICG) to identify neoplastic disease. For many pediatric solid tumors, complete resection of the prim…
The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with…
The main purpose of the study is the characterization of functional and morphological alterations due to multiple osteochondromas in a pediatric and adult popul…
There are no prospective studies of pregnancies for the diseases studied here in (Heredity Hemorrhagic Telangiectasia, Marfan syndrome or related, primary lower…
The project, funded by the PNRR under Mission 4 "Education and Research," aims to strengthen the network of Italian biobanks by improving data management in acc…
Children and adults with XLH recruited will be treated with calcitriol alone (without phosphate supplementation) for one year, during which the calcitriol dose…
"Ready to Sail 2 - EXTEND" is a pilot randomized interventional trial designed to assess the feasibility, safety, and preliminary impact of an innovative rehabi…